Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Constipation as an Atypical Presentation of Hyperparathyroidism: A Case Report.

The American journal of case reports·2025
Same author

Latest Insights in Alcohol-Related Liver Disease and Alcoholic Hepatitis.

Romanian journal of internal medicine = Revue roumaine de medecine interne·2025
Same author

Predictive Value of Several Parameters for Severity of Acute Pancreatitis in a Cohort of 172 Patients.

Diagnostics (Basel, Switzerland)·2025
Same author

Ultrasound Assessment of Sarcopenia in Alcoholic Liver Disease.

Diagnostics (Basel, Switzerland)·2024
Same author

Early Presentation of Boerhaave Syndrome in the Emergency Department: A Case Report and Review of the Literature.

Diagnostics (Basel, Switzerland)·2024
Same author

Model of disease severity in alcoholic hepatitis and novel prognostic insights.

Romanian journal of internal medicine = Revue roumaine de medecine interne·2024

Related Experiment Video

Updated: Jun 28, 2026

The Murine Choline-Deficient, Ethionine-Supplemented (CDE) Diet Model of Chronic Liver Injury
07:27

The Murine Choline-Deficient, Ethionine-Supplemented (CDE) Diet Model of Chronic Liver Injury

Published on: October 21, 2017

Acute-on-Chronic Liver Failure: Steps Towards Consensus.

Loredana Gabriela Goran1,2, Florina Alexandra Liţă Cofaru1,3, Carmen Fierbinţeanu-Braticevici1,2

  • 1Emergency University Hospital Bucharest, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.

Diagnostics (Basel, Switzerland)
|March 28, 2025
PubMed
Summary

Acute-on-chronic liver failure (ACLF) is a serious condition with high mortality. A consensus on its definition and management is crucial for effective treatment, as current understanding and approaches are still developing.

Keywords:
acute-on-chronic liver failureliver failureliver transplantorgan failure management

More Related Videos

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
09:44

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen

Published on: November 27, 2019

Inducing Acute Liver Injury in Rats via Carbon Tetrachloride (CCl4) Exposure Through an Orogastric Tube
06:12

Inducing Acute Liver Injury in Rats via Carbon Tetrachloride (CCl4) Exposure Through an Orogastric Tube

Published on: April 28, 2020

Related Experiment Videos

Last Updated: Jun 28, 2026

The Murine Choline-Deficient, Ethionine-Supplemented (CDE) Diet Model of Chronic Liver Injury
07:27

The Murine Choline-Deficient, Ethionine-Supplemented (CDE) Diet Model of Chronic Liver Injury

Published on: October 21, 2017

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
09:44

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen

Published on: November 27, 2019

Inducing Acute Liver Injury in Rats via Carbon Tetrachloride (CCl4) Exposure Through an Orogastric Tube
06:12

Inducing Acute Liver Injury in Rats via Carbon Tetrachloride (CCl4) Exposure Through an Orogastric Tube

Published on: April 28, 2020

Area of Science:

  • Hepatology
  • Internal Medicine
  • Critical Care Medicine

Background:

  • Acute-on-chronic liver failure (ACLF) is a severe clinical syndrome.
  • It is associated with high short-term mortality.
  • International definitions and diagnostic criteria for ACLF remain inconsistent.

Purpose of the Study:

  • To highlight the need for a unified definition and diagnostic criteria for ACLF.
  • To emphasize the importance of understanding ACLF's underlying mechanisms and inflammatory responses.
  • To underscore the necessity for developing specific management strategies for ACLF.

Main Methods:

  • Review of existing literature and definitions of ACLF.
  • Analysis of the role of precipitant factors and systemic inflammation in ACLF.
  • Discussion of current diagnostic and management challenges.

Main Results:

  • Multiple international organizations have proposed definitions for ACLF since 2013.
  • There is a lack of agreement on standardized diagnostic criteria.
  • Systemic inflammation and precipitant factors are recognized as key contributors to ACLF.

Conclusions:

  • A universally accepted definition and diagnostic criteria for ACLF are currently lacking.
  • Further research into the mechanisms of ACLF is required.
  • Development of a consensus for the diagnosis and management of ACLF is urgently needed to improve patient outcomes.